Related Experiment Videos
Xanthogranuloma is the archetype of non-Langerhans cell histiocytoses
The British Journal of Dermatology
|September 5, 2001
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Defining the actinic keratosis field: a literature review and discussion.
Journal of the European Academy of Dermatology and Venereology : JEADV·2017
The importance of patient-centred care to overcome barriers in the management of actinic keratosis.
Journal of the European Academy of Dermatology and Venereology : JEADV·2017
Acantholytic dermatosis of the vagina: the diagnostic challenge of acantholytic disease in the genital region.
Clinical and experimental dermatology·2017
Linear porokeratosis with multiple squamous cell carcinomas successfully treated by electrochemotherapy.
The British journal of dermatology·2016
Suppression of TGFβ and Angiogenesis by Type VII Collagen in Cutaneous SCC.
Journal of the National Cancer Institute·2015
Physician perceptions and experience of current treatment in actinic keratosis.
Journal of the European Academy of Dermatology and Venereology : JEADV·2014
Efficacy and Safety of Risankizumab in Paediatric Patients With Psoriasis in the OptIMMize-1 Phase III Study.
The British journal of dermatology·2026
Upadacitinib for Palmoplantar Pustulosis: An Open-label, Assessor-blinded Feasibility Study Using Historic Control Data (JAKPPPOT).
The British journal of dermatology·2026
Sustained response (ORR4) as an on-treatment prognostic marker in mogamulizumab-treated mycosis fungoides and Sézary syndrome: the FIL-MOGA study.
The British journal of dermatology·2026
Determinants of real-world sunscreen effectiveness: from ultraviolet radiation photobiology to human behaviour.
The British journal of dermatology·2026
Beyond the Surface of Long-term Survival in Stage IV Melanoma: A Multicenter Cross-sectional Study.
The British journal of dermatology·2026
Phloretin Modulates STING Ubiquitination Degradation to Restrain Dendritic Cell Overactivation and Alleviate Sjögren's Syndrome.
Pharmaceuticals (Basel, Switzerland)·2026